Evaluation of biomarkers and surrogate endpoints in chronic disease:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C.
National Academies Press
c2010
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description |
| Beschreibung: | 1 Online-Ressource (xx, 314 p.) |
| ISBN: | 0309151309 128278742X 9780309151306 9781282787421 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043134810 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 0309151309 |c electronic bk. |9 0-309-15130-9 | ||
| 020 | |a 128278742X |9 1-282-78742-X | ||
| 020 | |a 9780309151306 |c electronic bk. |9 978-0-309-15130-6 | ||
| 020 | |a 9781282787421 |9 978-1-282-78742-1 | ||
| 035 | |a (OCoLC)663886633 | ||
| 035 | |a (DE-599)BVBBV043134810 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 610.28 |2 22 | |
| 245 | 1 | 0 | |a Evaluation of biomarkers and surrogate endpoints in chronic disease |c Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors |
| 264 | 1 | |a Washington, D.C. |b National Academies Press |c c2010 | |
| 300 | |a 1 Online-Ressource (xx, 314 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references | ||
| 500 | |a Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation | ||
| 500 | |a "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description | ||
| 650 | 7 | |a TECHNOLOGY & ENGINEERING / Biomedical |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Family & General Practice |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Allied Health Services / Medical Technology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Biotechnology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Lasers in Medicine |2 bisacsh | |
| 650 | 7 | |a Biochemical markers / Evaluation |2 fast | |
| 650 | 7 | |a Chronic diseases |2 fast | |
| 650 | 4 | |a Biological Markers | |
| 650 | 4 | |a Chronic Disease | |
| 650 | 4 | |a Evidence-Based Practice | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Biochemical markers |x Evaluation | |
| 650 | 4 | |a Chronic diseases | |
| 700 | 1 | |a Micheel, Christine |e Sonstige |4 oth | |
| 700 | 1 | |a Ball, John |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 0-309-15129-5 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Paperback |z 978-0-309-15129-0 |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028559001 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175577834323968 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043134810 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)663886633 (DE-599)BVBBV043134810 |
| dewey-full | 610.28 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.28 |
| dewey-search | 610.28 |
| dewey-sort | 3610.28 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03242nmm a2200589zc 4500</leader><controlfield tag="001">BV043134810</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309151309</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-309-15130-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">128278742X</subfield><subfield code="9">1-282-78742-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309151306</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-309-15130-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781282787421</subfield><subfield code="9">978-1-282-78742-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)663886633</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043134810</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610.28</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of biomarkers and surrogate endpoints in chronic disease</subfield><subfield code="c">Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, D.C.</subfield><subfield code="b">National Academies Press</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xx, 314 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">"Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TECHNOLOGY & ENGINEERING / Biomedical</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Family & General Practice</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Allied Health Services / Medical Technology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Biotechnology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Lasers in Medicine</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biochemical markers / Evaluation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chronic diseases</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Markers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chronic Disease</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Evidence-Based Practice</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemical markers</subfield><subfield code="x">Evaluation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chronic diseases</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Micheel, Christine</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ball, John</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">0-309-15129-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Paperback</subfield><subfield code="z">978-0-309-15129-0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028559001</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043134810 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:18:30Z |
| institution | BVB |
| isbn | 0309151309 128278742X 9780309151306 9781282787421 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028559001 |
| oclc_num | 663886633 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xx, 314 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | National Academies Press |
| record_format | marc |
| spelling | Evaluation of biomarkers and surrogate endpoints in chronic disease Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors Washington, D.C. National Academies Press c2010 1 Online-Ressource (xx, 314 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references Review : evaluating and regulating biomarker use -- The biomarker evaluation process -- Case studies-- Strengthening evidence-based regulation "Many people naturally assume that the claims made for foods and nutritional supplements have the same degree of scientific grounding as those for medication, but that is not always the case. The IOM recommends that the FDA adopt a consistent scientific framework for biomarker evaluation in order to achieve a rigorous and transparent process."--Publisher's description TECHNOLOGY & ENGINEERING / Biomedical bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Lasers in Medicine bisacsh Biochemical markers / Evaluation fast Chronic diseases fast Biological Markers Chronic Disease Evidence-Based Practice Medizin Biochemical markers Evaluation Chronic diseases Micheel, Christine Sonstige oth Ball, John Sonstige oth Institute of Medicine (U.S.) Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease Sonstige oth Erscheint auch als Druck-Ausgabe, Paperback 0-309-15129-5 Erscheint auch als Druck-Ausgabe, Paperback 978-0-309-15129-0 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327 Aggregator Volltext |
| spellingShingle | Evaluation of biomarkers and surrogate endpoints in chronic disease TECHNOLOGY & ENGINEERING / Biomedical bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Lasers in Medicine bisacsh Biochemical markers / Evaluation fast Chronic diseases fast Biological Markers Chronic Disease Evidence-Based Practice Medizin Biochemical markers Evaluation Chronic diseases |
| title | Evaluation of biomarkers and surrogate endpoints in chronic disease |
| title_auth | Evaluation of biomarkers and surrogate endpoints in chronic disease |
| title_exact_search | Evaluation of biomarkers and surrogate endpoints in chronic disease |
| title_full | Evaluation of biomarkers and surrogate endpoints in chronic disease Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors |
| title_fullStr | Evaluation of biomarkers and surrogate endpoints in chronic disease Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors |
| title_full_unstemmed | Evaluation of biomarkers and surrogate endpoints in chronic disease Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease, Board on Health Care Services, Board on Health Sciences Policy, Food and Nutrition Board, Institute of Medicine ; Christine M. Micheel and John R. Ball, editors |
| title_short | Evaluation of biomarkers and surrogate endpoints in chronic disease |
| title_sort | evaluation of biomarkers and surrogate endpoints in chronic disease |
| topic | TECHNOLOGY & ENGINEERING / Biomedical bisacsh MEDICAL / Family & General Practice bisacsh MEDICAL / Allied Health Services / Medical Technology bisacsh MEDICAL / Biotechnology bisacsh MEDICAL / Lasers in Medicine bisacsh Biochemical markers / Evaluation fast Chronic diseases fast Biological Markers Chronic Disease Evidence-Based Practice Medizin Biochemical markers Evaluation Chronic diseases |
| topic_facet | TECHNOLOGY & ENGINEERING / Biomedical MEDICAL / Family & General Practice MEDICAL / Allied Health Services / Medical Technology MEDICAL / Biotechnology MEDICAL / Lasers in Medicine Biochemical markers / Evaluation Chronic diseases Biological Markers Chronic Disease Evidence-Based Practice Medizin Biochemical markers Evaluation |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=334327 |
| work_keys_str_mv | AT micheelchristine evaluationofbiomarkersandsurrogateendpointsinchronicdisease AT balljohn evaluationofbiomarkersandsurrogateendpointsinchronicdisease AT instituteofmedicineuscommitteeonqualificationofbiomarkersandsurrogateendpointsinchronicdisease evaluationofbiomarkersandsurrogateendpointsinchronicdisease |